Literature DB >> 33047609

The Correlation Between Endolymphatic Hydrops and blood-labyrinth barrier Permeability of Meniere Disease.

Weidong Zhang1, Jiapei Xie2, Lian Hui3, Songbai Li1, Bo Zhang1.   

Abstract

OBJECTIVES: This study was designed to assess the correlation between the grades of endolymphatic hydrops and the blood-labyrinth barrier permeability in the affected ear in Meniere's disease, following the administration of intravenous gadolinium contrast. STUDY
DESIGN: Prospective study.
METHODS: The quantitative values of endolymphatic hydrops were determined after intravenous injection of a double-dose of gadobutrol in 39 patients with unilateral definite Meniere's disease. Additionally, the signal intensity ratio of bilateral cochlear basal turns was evaluated and analyzed; The correlation between the grades of the endolymphatic hydrops and the signal intensity ratio of the cochlear basal turns in the affected ear was examined.
RESULTS: The grades of the endolymphatic hydrops can be quantitatively evaluated using magnetic resonance imaging (MRI). The signal intensity ratio of the cochlear basal turns in the affected ear was significantly higher than in the unaffected ear (P = .001); there was a positive correlation between the signal intensity ratio of the cochlear basal turn and the grades of cochlear (r = 0.634, P = 0.000) and vestibular(r = 0.559, P = .000) hydrops in the affected ear.
CONCLUSIONS: The increased permeability of the blood-labyrinth barrier may play a role in the process of endolymphatic hydrops in Meniere's disease.

Entities:  

Keywords:  Meniere’s disease; blood-labyrinth barrier; endolymphatic hydrops; signal intensity ratio

Mesh:

Substances:

Year:  2020        PMID: 33047609     DOI: 10.1177/0003489420964823

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  1 in total

Review 1.  Hearing Function, Degeneration, and Disease: Spotlight on the Stria Vascularis.

Authors:  Matsya R Thulasiram; Jacqueline M Ogier; Alain Dabdoub
Journal:  Front Cell Dev Biol       Date:  2022-03-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.